Tolga DÜZENLİ, Fatih BULUCU, Nazire Gökçe SOMAK, Harun ASLAN, Kenan SAĞLAM, Mithat ESER

Nabız Dalga Hızının Avrupa Kardiyoloji Derneği Koroner Risk Skorlaması ile İlişkisinin Belirlenmesi

GİRİŞ ve AMAÇ: Nabız dalga hızı kalp damar hastalıklarınıve aterosklerozu önleme açısından klinik kullanımda giderekönem kazanmaktadır. Bu çalışmada nabız dalga hızı ile AvrupaKardiyoloji Derneği risk skorlaması (ESC SCORE) arasındakiilişkiler araştırılmış ve kardiyovasküler hastalıklarıöngörmedeki rolleri tartışılmıştır. YÖNTEM ve GEREÇLER: Çalışma grubumuza nabız dalgahızı belirlenmiş toplam 713 birey dahil edilmiştir. Çalışmayaalınan bireylerin yaş, cinsiyet, sigara kullanımı, koroner arterhastalığı ve eşdeğeri hastalık mevcudiyeti, hipertansiyonvarlığı, kullandığı ilaçlar, ek hastalıklar incelendi. AvrupaKardiyoloji Derneği Heart-SCORE hesaplayıcısına girilerekhastaların total kardiyovasküler hastalık risk değeri belirlendi.Bu belirteçler ile nabız dalga hızı arasındaki ilişkileraraştırıldı. BULGULAR: 713 hastalık tüm grupta nabız dalga basıncıortalaması 8,86 m/s iken en küçük değer 5,30 m/s, en yüksekdeğer 17,70 m/s idi. ESC Score açısından ortalama skor 2,55;en küçük değer 0 ve en büyük değer 24 idi. Çalışmaya katılanhastaların nabız dalga hızları ve Avrupa Kardiyoloji Derneğikoroner risk skorları arasındaki korelasyon düşük düzey olaraksaptandı (r=0,288). KAH / eşdeğeri hastalığı olan ve olmayangruplar arasındaki ilişki incelendiğinde hem nabız dalga hızıve hem ESC skorları, hastalığı olanlarda yüksek idi (p

Pulse Wave Velocity and ESC SCORE (European Society ofCardiology Systematic Coronary Risk Evaluation)

INTRODUCTION: Pulse wave velocity has becomeincreasingly important in clinical use for the prevention ofcardiovascular disease and atherosclerosis. In this study, wehave investigated the relationship between pulse wave velocitywith European Society of Cardiology Systematic CoronaryRisk Evaluation (ESC Score) and discussed their roles forcardiovascular diseases (CVD). METHODS: 713 individuals followed at our outpatient clinicwere included in this study. The patients’ age, gender,smoking, history of coronary artery disease and equivalentdisease, hypertension, drug regimens, additional diseases wererecorded. Pulse wave velocities were measured using anarteriograph (Tensiomed). Online ESC-Score calculator wasused to determine total cardiovascular disease risk. Therelationship between scores and pulse wave velocity wereinvestigated. RESULTS: The mean of pulse wave velocity was 8.86 m/s ofwhole group, while the minimum and maximum values were5.30 m/s and 17.70 m/s, respectively. Mean ESC Score was2.55; as the minimum value 0 and the maximum value 24.Correlation between pulse wave velocity and the ESC Scorewas found to be low (r=0.288). In comparison between thegroups with and without CVD, pulse wave velocity and theESC scores were higher in patients with the disease (p

PDF

___

1. World Health Organization. Global status report on noncommunicable disaeses 2018. Geneva Switzerland, 2018.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442.
3. Refik Saydam Hıfzıssıhha Merkezi Başkanlığı. Türkiye Hastalık Yükü Çalışması 2004. SB Hıfzıssıhha Mektebi Müdürlüğü, 2006, p 10-20.
4. NCD Countdown 2030 collaborators. NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4. Lancet. 2020 Sep 3;396(10255):918–34.
5. Joseph P, Leong D, McKee M, et al. Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors. Circ Res. 2017;121(6):677-694.
6. Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and allcause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052-2090.
7. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003 Jun;24(11):987-1003.
8. Palombo C, Kozakova M. Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol. 2016 Feb;77:1-7.
9. Sequí-Domínguez I, Cavero-Redondo I, ÁlvarezBueno C, Pozuelo-Carrascosa DP, Nuñez de ArenasArroyo S, Martínez-Vizcaíno V. Accuracy of Pulse Wave Velocity Predicting Cardiovascular and All-Cause Mortality. A Systematic Review and Meta-Analysis. J Clin Med. 2020;9(7):2080.
10. Lioufas N, Hawley CM, Cameron JD, Toussaint ND. Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review. Int J Hypertens. 2019 Feb 17;2019:9189362.
11. Saji N, Toba K, Sakurai T. Cerebral Small Vessel Disease and Arterial Stiffness: Tsunami Effect in the Brain?. Pulse (Basel). 2016;3(3-4):182-189.
12. Milan A, Zocaro G, Leone D, et al. Current assessment of pulse wave velocity: comprehensive review of validation studies. J Hypertens. 2019;37(8):1547-1557.
13. Pereira T, Maldonado J, Polónia J, et al. Aortic pulse wave velocity and HeartSCORE: Improving cardiovascular risk stratification. A sub-analysis of the EDIVA (Estudo de DIstensibilidade VAscular) project. Blood Press. 2014 Apr;23(2):109-15.
14. Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010 Apr;31(7):883-91.
15. Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction, An Individual Participant MetaAnalysis of Prospective Observational Data From 17,635 Subjects. J Am Coll Cardiol. 2014 Feb 25;63(7):636-46.
16. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006 Feb 7;113(5):664-70.
17. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2046- 50.
18. Wilson J, Webb AJS. Systolic Blood Pressure and Longitudinal Progression of Arterial Stiffness: A Quantitative Meta-Analysis. J Am Heart Assoc. 2020 Sep;9(17):e017804.
19. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27.
20. Kim JM, Kim SS, Kim IJ, et al. Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study. Cardiovasc Diabetol. 2020;19(1):143.
21. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial Stiffness and Cardiovasculer Events The Framingham Heart Study, Circulation. 2010 Feb 2;121(4):505-11.